Literature DB >> 23647276

Therapeutic potential of cell-penetrating peptides.

Luís Vasconcelos1, Kalle Pärn, Ulo Langel.   

Abstract

The ability of cell-penetrating peptides to cross plasma membranes has been used for various applications, including the delivery of bioactive molecules to inhibit disease-producing cellular mechanisms. Selective drug delivery into target cells improves drug distribution and decreases dosing and toxicity. In this review, the authors outline the main challenges in the field, namely clarification of mechanisms of entry into cells, as well as current and future perspectives regarding cell-penetrating peptides application for human therapeutics. Here, the authors discuss some of the factors that influence efficacy of delivery and review the current status of preclinical studies and clinical trials involving the use of cell-penetrating peptide-mediated delivery of therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647276     DOI: 10.4155/tde.13.22

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  19 in total

1.  A peptide for transcellular cargo delivery: Structure-function relationship and mechanism of action.

Authors:  Alexander Komin; Maxim I Bogorad; Ran Lin; Honggang Cui; Peter C Searson; Kalina Hristova
Journal:  J Control Release       Date:  2020-05-28       Impact factor: 9.776

Review 2.  High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.

Authors:  Bainan Wu; Elisa Barile; Surya K De; Jun Wei; Angela Purves; Maurizio Pellecchia
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.

Authors:  Gianvito Grasso; Mathieu Heulot; Nadja Chevalier; Evgeniya Trofimenko; Marco A Deriu; Gilles Dubuis; Yoan Arribat; Marc Serulla; Sebastien Michel; Gil Vantomme; Florine Ory; Linh Chi Dam; Julien Puyal; Francesca Amati; Anita Lüthi; Andrea Danani; Christian Widmann
Journal:  Elife       Date:  2021-10-29       Impact factor: 8.140

4.  Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation.

Authors:  Alistair Taverner; Ruggero Dondi; Khaled Almansour; Floriane Laurent; Siân-Eleri Owens; Ian M Eggleston; Nikoletta Fotaki; Randall J Mrsny
Journal:  J Control Release       Date:  2015-05-14       Impact factor: 9.776

5.  Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.

Authors:  Suresh Ramakrishna; Abu-Bonsrah Kwaku Dad; Jagadish Beloor; Ramu Gopalappa; Sang-Kyung Lee; Hyongbum Kim
Journal:  Genome Res       Date:  2014-04-02       Impact factor: 9.043

Review 6.  Promises and pitfalls of intracellular delivery of proteins.

Authors:  Ailing Fu; Rui Tang; Joseph Hardie; Michelle E Farkas; Vincent M Rotello
Journal:  Bioconjug Chem       Date:  2014-09-02       Impact factor: 4.774

Review 7.  Type II CRISPR/Cas9 approach in the oncological therapy.

Authors:  A Biagioni; A Chillà; E Andreucci; A Laurenzana; F Margheri; S Peppicelli; M Del Rosso; G Fibbi
Journal:  J Exp Clin Cancer Res       Date:  2017-06-15

8.  Peptides Interfering 3A Protein Dimerization Decrease FMDV Multiplication.

Authors:  Mónica González-Magaldi; Ángela Vázquez-Calvo; Beatriz G de la Torre; Javier Valle; David Andreu; Francisco Sobrino
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

9.  The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.

Authors:  Kristopher Montrose; Yi Yang; Geoffrey W Krissansen
Journal:  Sci Rep       Date:  2014-05-09       Impact factor: 4.379

10.  Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac.

Authors:  Yousuf Mohammed; Meritxell Teixidó; Sarika Namjoshi; Ernest Giralt; Heather Benson
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.